Preoperative neutrophil lymphocyte ratio but not platelet lymphocyte ratio predicts survival and early relapse in patients with oral, pharyngeal, and lip cancer

Head Neck. 2019 May;41(5):1468-1474. doi: 10.1002/hed.25580. Epub 2019 Jan 11.

Abstract

Background: To evaluate the prognostic value of preoperative neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in oral, pharyngeal, and lip cancer for survival and relapse.

Methods: Clinic-pathologic and hematological records were retrospectively retrieved. Patients completed follow-up period were included for survival and relapse analysis.

Results: The preoperative NLR value was a prognostic factor for both overall survival and relapse-free survival. The high NLR group demonstrated higher total relapse rate, higher local relapse rate, and higher relapse rate within 12 months. However, the preoperative PLR did not associate with survival or relapse.

Conclusions: The preoperative NLR, not PLR, is an independent prognostic indicator of survival. It also exhibits predictive value for relapse, particularly early relapse within 12 months. The preoperative NLR value might be recommended as a useful tool for predicting the outcomes and stratifying patients for different management strategies.

Keywords: neutrophil lymphocyte ratio; oral, pharyngeal and lip cancer; overall survival; platelet lymphocyte ratio; relapse rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • China
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Hospitals, University
  • Humans
  • Lip Neoplasms / mortality*
  • Lip Neoplasms / pathology
  • Lip Neoplasms / surgery
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Mouth Neoplasms / mortality*
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / surgery
  • Neoplasm Recurrence, Local / blood*
  • Neoplasm Recurrence, Local / diagnosis
  • Neutrophils
  • Pharyngeal Neoplasms / mortality*
  • Pharyngeal Neoplasms / pathology
  • Pharyngeal Neoplasms / surgery
  • Platelet Count
  • Predictive Value of Tests
  • Preoperative Care / methods
  • Retrospective Studies
  • Survival Analysis

Substances

  • Biomarkers, Tumor